Knoll Capital Management, LLC - Q3 2023 holdings

$96.3 Million is the total value of Knoll Capital Management, LLC's 37 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 51.9% .

 Value Shares↓ Weighting
ALDX BuyAldeyra Therapeutics Inc$20,253,192
-20.0%
3,031,915
+0.5%
21.02%
-31.5%
APLT BuyApplied Therapeutics Inc$12,853,599
+191.1%
5,162,088
+49.6%
13.34%
+149.2%
BHVN BuyBiohaven Pharmactl Hldg Co L$12,755,876
+18.4%
490,422
+8.9%
13.24%
+1.4%
AVDL BuyAvadel Pharmaceuticals Plcsponsored adr$6,180,000
-25.0%
600,000
+20.0%
6.42%
-35.8%
HOOK  HOOKIPA PHARMA$3,398,709
-30.0%
5,517,3850.0%3.53%
-40.1%
VRNA  Verona Pharmasponsored ads$3,260,000
-22.9%
200,0000.0%3.38%
-34.0%
SA BuySEABRIDGE GOLD INC$2,601,598
+169.9%
246,597
+208.2%
2.70%
+131.1%
GDX  Vaneck Gold Miners ETFgold miners etf$2,471,683
-10.6%
91,8500.0%2.57%
-23.5%
SIL  Global X Silver Miners ETF 37954Y848global x silver$2,143,830
-8.0%
89,7000.0%2.22%
-21.3%
KGC NewKinross Gold Corp$2,006,400440,000
+100.0%
2.08%
FNV BuyFranco Nev Corp CAD$1,935,605
+93.9%
14,500
+107.1%
2.01%
+66.0%
WPM NewWheaton Precious Metals Corp$1,926,12547,500
+100.0%
2.00%
AEM NewAgnico Eagle Mines Ltd$1,818,00040,000
+100.0%
1.89%
SILV BuySilvercrest Metals Inc CAD$1,808,100
+81.5%
410,000
+141.2%
1.88%
+55.4%
ENTX  Entera Bio Ltd$1,801,099
-14.0%
2,484,2750.0%1.87%
-26.3%
EQX NewEquinox Gold Corp$1,780,529420,929
+100.0%
1.85%
GDXJ  Vaneck Junior Gold Miners ETFjunior hold mine$1,713,024
-9.6%
53,1500.0%1.78%
-22.6%
MAG NewMag Silver Corp$1,659,200160,000
+100.0%
1.72%
BAH  Booz Allen Hamilton HLDG CORcl a$1,420,510
-2.1%
13,0000.0%1.48%
-16.1%
AG NewFirst Majestic Silver Corp$1,410,750275,000
+100.0%
1.46%
V  Visa$1,115,548
-3.1%
4,8500.0%1.16%
-17.0%
TMO  Thermo Fischer Scientific Inc$1,062,957
-3.0%
2,1000.0%1.10%
-16.9%
CVS  CVS Health Corp$1,012,390
+1.0%
14,5000.0%1.05%
-13.5%
MO  Altria Group Inc$954,535
-7.2%
22,7000.0%0.99%
-20.5%
NOC  Northrop Grumman Corp$953,011
-3.4%
2,1650.0%0.99%
-17.3%
AGI NewAlamos Gold Inc$903,20080,000
+100.0%
0.94%
LMT NewLockheed Martin Corp$879,2642,150
+100.0%
0.91%
RGLD NewRoyal Gold Inc.$802,7917,550
+100.0%
0.83%
PAAS NewPan American Silver Corp$783,15054,085
+100.0%
0.81%
OR  OSISKO GOLD ROYALTIES LTD$732,000
-24.5%
400,0000.0%0.76%
-35.3%
NewAmylyx$453,57524,772
+100.0%
0.47%
ORGS  Orgenesis, Inc.$393,537
-55.4%
634,7380.0%0.41%
-61.8%
 Omega Therapeutics Inc.$371,971
-61.6%
173,0100.0%0.39%
-67.1%
OCUP  Ocuphire Pharma Inc.$335,000
-22.8%
100,0000.0%0.35%
-33.8%
NEWP NewNew Pac Metals Corp$233,027131,654
+100.0%
0.24%
BTAI BuyBioXcell$151,800
-24.0%
60,000
+100.0%
0.16%
-34.7%
OCUL SellOcular Therapeutix Inc.$1,256
-99.9%
400
-99.8%
0.00%
-99.9%
ALT ExitAltimmune Inc$0-173,864
-100.0%
-0.74%
OCUL ExitOcular Therapeutix Inc.call$0-95,800
-100.0%
-0.99%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-11-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
Aldeyra Therapeutics Inc35Q3 202331.6%
Corbus Pharmaceuticals HLDGS30Q3 202246.5%
Abeona Therapeutics Inc30Q3 202234.8%
Biohaven Pharmactl Hldg Co L26Q3 202379.6%
Entera Bio Ltd22Q3 20237.8%
Ampio Pharmaceuticals Inc.21Q2 201811.0%
Soligenix Inc.20Q3 20221.7%
Eiger Biopharmaceuticals Inc19Q3 20225.8%
Applied Therapeutics Inc18Q3 202319.7%
Alcobra Ltd18Q3 20176.5%

View Knoll Capital Management, LLC's complete holdings history.

Latest significant ownerships (13-D/G)
Knoll Capital Management, LLC Q3 2023 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
HOOKIPA Pharma Inc.June 20, 20235,517,3856.8%
Applied Therapeutics Inc.January 23, 20233,450,0007.2%
Orgenesis Inc.August 14, 20201,316,3645.9%
Corbus Pharmaceuticals Holdings, Inc.February 14, 20205,045,8707.1%
ABEONA THERAPEUTICS INC.February 14, 20182,359,7675.0%
SOLIGENIX, INC.November 13, 2017870,0009.9%
ABEONA THERAPEUTICS INC.February 14, 20172,359,7675.9%
ALCOBRA LTD.February 14, 20171,205,4984.4%
Ampio Pharmaceuticals, Inc.February 14, 20172,738,3224.8%
RITTER PHARMACEUTICALS INCFebruary 14, 2017952,4348.2%

View Knoll Capital Management, LLC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-14
SC 13G/A2024-01-16
13F-HR2023-11-14
SC 13G2023-10-04
13F-HR2023-08-15
SC 13G2023-06-20
13F-HR2023-05-15
13F-HR2023-02-14
SC 13G2023-01-23
13F-HR2022-11-14

View Knoll Capital Management, LLC's complete filings history.

Compare quarters

Export Knoll Capital Management, LLC's holdings